Cite
HARVARD Citation
Mease, P. et al. (n.d.). FRI0201 Analysis of infection risk in patients with limited return of peripheral B cells after a period of 2 years or more following any rituximab treatment course in RA clinical trials. Annals of the rheumatic diseases. p. 381. [Online].